Release date: 2007-03-23
A groundbreaking development in medical technology has emerged from the UK, where scientists have created a new type of artificial "spiral" blood vessel. This innovative device, developed by Tayside Technology on behalf of the British National Health Service, offers hope to millions suffering from arterial occlusive disease. The findings were published in the prestigious *Lancet* medical journal.
The newly designed plastic blood vessels were tested in human patients, and within the first six months of the trial, they successfully performed their intended medical function. These artificial arteries are used during surgical procedures and differ significantly from traditional grafts. Instead of being straight, they feature a unique spiral structure that mimics the motion of a bullet, allowing blood to flow in a more natural, spiraling pattern through the body.
So far, none of the implanted "spiral" vessels have become blocked, and their performance has remained consistently stable. Blood vessels play a vital role in transporting oxygen and essential nutrients throughout the body. Diseases such as arterial occlusion and aneurysms can be life-threatening, especially when they affect major arteries. If not treated promptly, these conditions can lead to severe complications or even death.
Researchers at Tayside Technology emphasized the significance of this innovation, stating that they invested millions to validate the effectiveness of this new technology. They believe this development marks a major milestone in medical science. The team is now extending the human trials for an additional six months, with plans to begin commercial production once the results are confirmed. The project is estimated to cost £6 million, and the global market for artificial blood vessels is expected to reach $300 million (£155 million) in the near future.
This breakthrough could revolutionize vascular surgery, offering safer and more effective alternatives for patients in need of arterial replacement. As the technology continues to evolve, it may one day become a standard treatment option for those suffering from circulatory diseases worldwide.
Vsstech Co.,Ltd. , https://www.vsstechcctv.com